Regarding the last part of your post, I don’t think it
Regarding the last part of your post, I don’t think it was Dr Jay’s communications at all that resulted in “The Letter”: The previous blunders, amateur approaches and incomplete/mis-formatted BLA filings as well as blatantly ignoring the FDA warnings contributed. The bogus press releases and Proactive videos made anyone with knowledge of the rules that are expected in PhRMA/Biotech and regulatory affairs, cringe as they were so out of line with what can legally (jmo - not legal advice) be said from a company either developing a drug or one that has already been approved.
It is a very serious offense to misrepresent a drug before it has passed certain hurdles established by the FDA. That is not a slight whatsoever on the efficacy of LL and what we all were witnessing across multiple disease states. You just can’t use words like (these are my words)- Amazing, Better, Beautiful…; this is a standard (and bare minimum) understanding in the Industry and NP didn’t get that. The Amerex debacle made things terrible for LL to get approved.
Then there was a pitchforks and torches period where mob mentality ruled and cydy enthusiasts were pressing to write the FDA and demand approval, without LL having passed the proper regulatory hurdles. The FDA took this to mean thar NP ‘s premature and out of bounds languaging was getting through to the “Lay” (their word from the letter) and they have to take that seriously because it, again, Hadn’t gone through the proper regulatory process and cross the proper hurdles to obtain approval.
What is the letter harsh? Absolutely. Could it have been handled a different way? Absolutely. I disagree with many of the characterizations of LL in that letter, but the letter was not caused by Dr. Jay. It was years in the making from the fumblers of Amerex Along with the points that I have noted above.
*I again implore folks to let SA handle things.
Having said that I am 100% confident that Dr. Jay is the right man for the job and I say this because of the way he speaks. Like it or not, he has to be respectful of the FDA and he has to speak and write in a language that Does not trigger them. They are bureaucrats and they work under a system. That system has certain steps that must occur and If you step out of line, they will push back. Dr. Jay understands this and his experience in clinical trials and regulatory affairs of drug approvals are a godsend to our cause. His passion for improving, the lives of patience is a bonus to say the least.
20
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Security software caught a bid while the rest of the tape was getting kicked down the stairs. That contrast is the whole story: investors saw Palo Alto Networks deliver a strong fiscal first quarter and raise its fiscal 2027 outlook, then decided cyber defense may be one of the few technology budgets companies cannot casually postpone. With AI helping attackers locate and...
Continue Reading
Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...
Continue Reading
A 19.17% opening haircut is the market ringing the fire alarm, not politely clearing its throat. Liquidity Services reported fiscal fourth-quarter revenue of $106.4 million, roughly 10% below the prior-year quarter, and shareholders got hit hard on November 19, 2026. That reaction is ugly, but it is not mysterious. When a company built around moving surplus inventory...
Continue Reading
A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...
Continue Reading
A bot can spit out a feature before lunch, then leave a repair bill nobody budgeted for. That is the uncomfortable issue behind Appian's new research on AI-assisted software development: speed is easy to celebrate, while ownership gets shoved into a dark corner until something breaks. Appian said on November 20, 2026, that two-thirds of surveyed AI decision-makers and IT...
Continue Reading
A corrected headline is a small wrinkle, but the underlying chargeback mess is not. Chargeflow and Juniper Research surveyed 121 senior executives at U.S. and U.K. businesses with at least $100 million in annual gross merchandise value, and the useful takeaway is painfully clear: merchants are putting AI on the label without rebuilding the machinery underneath. That...
Continue Reading
A toddler surviving on three bites Tuesday is not a verdict on the family table. That plain idea sits at the center of pediatric expert Kathy Shirazi’s guidance on childhood nutrition, and frankly, it deserves more oxygen than another impossible-looking lunchbox photo. In the HelloNation article released November 20, 2026, Shirazi, MD, MPH, FAAP, urges parents to judge...
Continue Reading
Private-market paperwork has long been a swamp of portals, PDFs, email chains, and somebody chasing down a wire change at the worst possible moment. Anduin is taking a swing at that mess by opening its Investor Portal to all customers after building it with leading asset managers and operating it with their investors. The pitch is sensible: give limited partners one...
Continue Reading
Agency technology hires usually land with all the thunder of a stapler dropping, but this one deserves a closer look. Mindgruve has named Steve Terjeson vice president of technology, handing a former WPP Choreograph executive the job of leading its software development and data engineering teams. The assignment is not vague: push AI innovation, make the proprietary...
Continue Reading
Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...
Continue Reading
Top 5 Most Recently Viewed Articles
Celebration of Pop Culture at Macy's Thanksgiving Parade With excitement in the air, POP MART is gearing up for a remarkable debut at the iconic Macy's Thanksgiving Day Parade. This year marks an enchanting chapter as the brand unveils its unique float, themed "Friendsgiving in POP CITY," showcasing an array of beloved characters from the POP MART universe. The event will...
Continue Reading
NEC X Invites Applications for Innovative Venture Programs NEC X, a dynamic venture studio based in Silicon Valley, is now opening its doors for applications to the Elev X! Ignite program. This initiative is geared towards transforming promising early-stage startups into fully developed businesses ready for investment. With the potential for up to $200,000 in equity...
Continue Reading
Palatin Technologies Unveils Innovative Approaches for Inflammation Palatin Technologies, Inc. (NYSE American: PTN), a pioneering biopharmaceutical company, has recently showcased significant advancements in the treatment of inflammatory diseases. The firm, known for its first-in-class medicines based on melanocortin receptor modulation, delivered compelling data during...
Continue Reading
Drumstick Launches Game-Changing Peanut Butter Sundae Cones A warm welcome to all peanut butter aficionados! Drumstick®, one of America's beloved sundae cone brands, has introduced a delightful new flavor aimed squarely at peanut butter lovers. This exciting launch brings amazing peanut butter and chocolate peanut butter sundae cones to grocery stores across the nation....
Continue Reading
Michael Saylor's Vision on Quantum Computing's Impact on Bitcoin Michael Saylor, the Executive Chairman of Strategy Inc. (NASDAQ: MSTR), has made a strong claim regarding the potential influence of quantum computing on Bitcoin. On social media, he emphasized his belief that quantum computing will not undermine Bitcoin, the leading cryptocurrency, but instead enhance its...
Continue Reading